Description:
Aripiprazole lauroxil is a Dopamine D2 receptor agonist, Serotonin 1A receptor agonist and ISerotonin 2A receptor antagonist under the development of Alkermes plc. Aripiprazole lauroxil is applicated as long-acting injectable atypical antipsychotic for the treatment of schizophrenia. It is an N-acyloxymethyl prodrug of aripiprazole
- Molecular Weight:660.72
- Purity:98%
Molecular Formula:
C36H51Cl2N3O4
Canonical SMILES:
CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=C1C=C(C=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl
InChI:
InChI=1S/C36H51Cl2N3O4/c1-2-3-4-5-6-7-8-9-10-16-35(43)45-28-41-33-27-30(19-17-29(33)18-20-34(41)42)44-26-12-11-21-39-22-24-40(25-23-39)32-15-13-14-31(37)36(32)38/h13-15,17,19,27H,2-12,16,18,20-26,28H2,1H3
InChIKey:
DDINXHAORAAYAD-UHFFFAOYSA-N
Solubility:
Soluble in DMSO
Appearance:
Powder
Application:
Schizophrenia
Storage: -20°C Freezer
Synonyms:
Aristada; RDC-3317; RDC 3317; RDC3317; UNII-B786J7A343; ALKS 9070; ALKS9070; ALKS-9070; ALKS 9072; ALKS-9072; ALKS9072; [7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-2-oxo-3,4-dihydroquinolin-1-yl]methyl dodecanoate Más detalles se encuentran
aquí